Role of surgical intervention in unresectable non-small cell lung cancer

S Suzuki, T Goto - Journal of Clinical Medicine, 2020 - mdpi.com
With the development of systemic treatments with high response rates, including tyrosine
kinase inhibitors and immune checkpoint inhibitors, some patients with unresectable lung …

Endoscopic Technologies for Peripheral Pulmonary Lesions: From Diagnosis to Therapy

A Fantin, M Manera, V Patruno, G Sartori, N Castaldo… - Life, 2023 - mdpi.com
Peripheral pulmonary lesions (PPLs) are frequent incidental findings in subjects when
performing chest radiographs or chest computed tomography (CT) scans. When a PPL is …

[HTML][HTML] Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer

A Hamada, J Soh, T Mitsudomi - Translational Lung Cancer …, 2021 - ncbi.nlm.nih.gov
Definitive chemoradiotherapy (CRT) has been a standard of care for patients with
unresectable stage III non-small cell lung cancer (NSCLC). However, locoregional …

Safety of salvage lung resection after immunotherapy for unresectable non-small cell lung cancer

T Ueno, M Yamashita, N Yamashita, M Uomoto… - General Thoracic and …, 2022 - Springer
Background The safety of salvage lung resection after immune checkpoint inhibitor (ICI)
therapy in patients with advanced non-small cell lung cancer (NSCLC) is not well …

Salvage surgery in lung cancer following definitive therapies

M Eisenberg, N Deboever… - Journal of surgical …, 2023 - Wiley Online Library
Salvage surgery refers to operative resection of persistent or recurrent disease in patients
initially treated with intention‐to‐cure nonoperative management. In non‐small‐cell lung …

Diagnosis and management of patients with stage III non‑small cell lung cancer: A joint statement by the Lebanese Society of Medical Oncology and the Lebanese …

Z Aoun-Bacha, N Bitar, WA Saleh… - Oncology …, 2023 - spandidos-publications.com
Proper management of stage III non-small cell lung cancer (NSCLC) might result in a cure or
patient long-term survival. Management should therefore be preceded by adequate and …

Salvage surgery for local recurrence after sublobar surgery in stages I and II non‐small cell lung cancer

DP Dolan, DN Lee, S Kucukak… - Journal of surgical …, 2022 - Wiley Online Library
Abstract Background and Objectives To examine if patients undergoing salvage surgery for
local recurrence following sublobar resection (SLR) have similar perioperative …

Salvage surgery after immune checkpoint inhibitors for advanced non-small cell lung cancer: potential association between immune-related adverse events and …

S Nagata, M Hamaji, H Ozasa, Y Yamada, A Ohsumi… - Clinical Lung Cancer, 2022 - Elsevier
Clinical Practice Points• The emergence of immune checkpoint inhibitors (ICIs) has
improved the long-term survival outcomes in patients with advanced non-small cell lung …

Patient selection for local aggressive treatment in oligometastatic non-small cell lung cancer

RS Werner, I Opitz - Cancers, 2021 - mdpi.com
Simple Summary Since the first introduction of the oligometastatic state with a low burden of
metastases in non-small cell lung cancer, accumulating evidence from retrospective and …

Dynamic changes in pathology and PD‐L1 expression in a patient with metastatic lung adenocarcinoma who received pembrolizumab therapy followed by two …

G Hong, HS Park, MK Yeo, D Lee, C Chung - Thoracic Cancer, 2023 - Wiley Online Library
During chemotherapy, certain cancer cells undergo cell death, which alters the properties of
remaining cells and leads to numerous changes in the constituent cells of lung cancer …